Search Results 111-120 of 17043 for nivolumab
Giving nivolumab with the usual chemotherapy may work better than the usual chemotherapy alone in treating patients with nasopharyngeal cancer. Perfusion ...
SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...
... nivolumab in each disease cohort, both across and within tumor biomarker subgroups. ... SC nivolumab in-home treatment may be safe, tolerable and/or ...
This phase II trial studies how well nivolumab and brentuximab vedotin work in treating older patients with untreated Hodgkin lymphoma. Monoclonal antibodies, ...
... nivolumab in six (21%) patients, atezolizumab in four (14%) patients, ipilimumab and nivolumab combination therapy in four (14%) patients, avelumab in one ...
... Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301). Jacksonville, Fla. The purpose of this study is for IMC-F106C plus nivolumab ...
Immunotherapy with antibodies, such as nivolumab and ipilimumab, may remove the brake on the body's immune system and may interfere with the ability of tumor ...
Giving nivolumab before nephrectomy may make the tumor smaller and reduce the amount of normal tissue that needs to be removed, and after nephrectomy to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!